Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Immunology

• Publication date

  2011-11-15

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.4049/jimmunol.1100225PMID 22013115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese‐diabetic mice

  2011cited by this paper
• Saturated‐efferocytosis generates pro‐resolving CD11blow macrophages: Modulation by resolvins and glucocorticoids

  2011cited by this paper
• Resolvin D1 binds human phagocytes with evidence for proresolving receptors

  2010cited by this paper
• Disruption of the 12/15‐lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease

  2010cited by this paper
• Adipose tissue, inflammation and atherosclerosis.

  2010cited by this paper
• Dynamic, M2-Like Remodeling Phenotypes of CD11c+ Adipose Tissue Macrophages During High-Fat Diet–Induced Obesity in Mice

  2010cited by this paper
• 5-Lipoxygenase Activating Protein Signals Adipose Tissue Inflammation and Lipid Dysfunction in Experimental Obesity

  2010cited by this paper
• Specialized pro-resolving lipid mediators in the inflammatory response: An update.

  2010cited by this paper
• Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

  2009cited by this paper
• Resolvin D1 controls inflammation initiated by glutathione‐lipid conjugates formed during oxidative stress

  2009cited by this paper
• Alternative activation of macrophages: an immunologic functional perspective.

  2009cited by this paper
• n-3 PUFA: bioavailability and modulation of adipose tissue function

  2009cited by this paper
• The metabolic syndrome of omega3-depleted rats. II. Body weight, adipose tissue mass and glycemic homeostasis.

  2009cited by this paper
• PRESS echo time behavior of triglyceride resonances at 1.5T: detecting omega-3 fatty acids in adipose tissue in vivo.

  2009cited by this paper
• Transgenic expression of n‐3 fatty acid desaturase (fat‐1) in C57/BL6 mice: Effects on glucose homeostasis and body weight

  2009cited by this paper
• Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins

  2009influential reference
• PPAR gamma is highly expressed in F4/80(hi) adipose tissue macrophages and dampens adipose-tissue inflammation.

  2009cited by this paper
• Phenotypic Switching of Adipose Tissue Macrophages With Obesity Is Generated by Spatiotemporal Differences in Macrophage Subtypes

  2008cited by this paper
• Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

  2008cited by this paper
• Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP

  2008cited by this paper
• Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition

  2008cited by this paper
• Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation

  2008cited by this paper
• Resolvin D1 and Its Aspirin-triggered 17R Epimer

  2007cited by this paper
• Candida albicans Modulates Host Defense by Biosynthesizing the Pro-Resolving Mediator Resolvin E1

  2007cited by this paper
• Resolvin E1 and protectin D1 activate inflammation-resolution programmes

  2007cited by this paper
• Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids

  2007cited by this paper
• Obesity‐induced inflammation: a metabolic dialogue in the language of inflammation

  2007cited by this paper
• Obesity induces a phenotypic switch in adipose tissue macrophage polarization.

  2007cited by this paper
• Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n−3 polyunsaturated fatty acids

  2006cited by this paper
• Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women

  2006cited by this paper
• Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA

  2006cited by this paper
• Resolution of in flammation: state of the art, definitions and terms

  2006cited by this paper
• Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss.

  2005cited by this paper
• Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

  2005cited by this paper
• Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis.

  2005cited by this paper
• Regulation of immune responses by L-arginine metabolism

  2005cited by this paper
• Alternative activation of macrophages

  2003cited by this paper
• Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

  2003cited by this paper
• Obesity is associated with macrophage accumulation in adipose tissue.

  2003cited by this paper
• Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase.

  2003cited by this paper
• Obesity-induced inflammatory changes in adipose tissue.

  2003cited by this paper
• Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells

  2003cited by this paper
• Resolvins

  2002cited by this paper
• Age-dependent responses of the serum non-esterified fatty acids to adrenalectomy and ovariectomy in developing rats.

  1984cited by this paper

• Herring roe PLs promote SPM biosynthesis in macrophages and a keratinocyte/fibroblast co-culture as model of psoriasis

  2026cites this paper
• Immunomodulatory Effects of Omega‐3 Fatty Acids: Mechanistic Insights and Health Implications

  2025cites this paper
• The effect of dietary camelina, flaxseed, and canola oil supplementation on skin fatty acid profile and immune and inflammatory responses in healthy adult horses

  2025cites this paper
• Formylpeptide receptors: A novel target to treat cardiometabolic complications.

  2025cites this paper
• An orally budesonide-loaded yeast microcapsules-based gel relieves IgA nephropathy via the modulation of gut-kidney axis

  2025cites this paper
• Leukocyte-type 12/15-lipoxygenase is essential for timely inflammation-resolution and effective tissue regeneration following skeletal muscle injury

  2025cites this paper
• Omega-3 Polyunsaturated Fatty Acids in Chronic Obstructive Pulmonary Disease Patients with COVID-19: A Review

  2025cites this paper
• Lack of effects of Resolvin D1 after spinal cord injury in mice.

  2025cites this paper
• Novel Resolvin D1-Loaded Biologics as an Advanced Approach for Inflammation Control and Tissue Regeneration: Preparation and Characterization

  2025cites this paper
• The Complex Role of Neutrophils in Healthy Ageing, Inflammageing and Frailty.

  2025cites this paper
• Abundances but not concentrations of circulating unsaturated fatty acids are associated with incident psoriatic diseases: Evidence from cohort and Mendelian randomization studies

  2025cites this paper
• Exercise-Stimulated Resolvin Biosynthesis in the Adipose Tissue Is Abrogated by High-Fat Diet–Induced Adrenergic Deficiency

  2025cites this paper
• Beneficial effects of long-chain n-3 fatty acids on insulin-resistance: basic and clinical aspects.

  2025cites this paper
• Specialized pro-resolving lipid mediators: a key player in resolving inflammation in autoimmune diseases.

  2025cites this paper
• Type I IFN receptor blockade alleviates liver fibrosis through macrophage-derived STAT3 signaling

  2025cites this paper
• Preclinical therapeutics for sickle cell disease: modern developments and future considerations

  2025cites this paper
• Macrophage Polarization in Lung Diseases: From Mechanisms to Therapeutic Strategies

  2025cites this paper
• Novel insights into the hepatoprotective mechanisms of SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

  2025cites this paper
• Role and mechanism of specialized pro-resolving mediators in obesity-associated insulin resistance

  2024influential citation
• Deciphering the Potential Role of Specialized Pro-Resolving Mediators in Obesity-Associated Metabolic Disorders

  2024cites this paper
• Exacerbation of atherosclerosis, hyperlipidemia and inflammation by MK886, an inhibitor of leukotriene biosynthesis, in obese and diabetic mice

  2024cites this paper
• Inflammation and resolution in obesity

  2024influential citation
• Insight into the role of macrophages in periodontitis restoration and development

  2024cites this paper
• Resolvinas, un importante coadyuvante en el manejo de la periodontitis

  2024cites this paper
• Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis

  2024cites this paper
• Macrophage polarization and metabolic reprogramming in abdominal aortic aneurysm

  2024cites this paper
• Genome-wide DNA methylome and transcriptome profiling reveals key genes involved in the dysregulation of adipose-stem cells in Crohn's disease.

  2024cites this paper
• Attenuation of adipose tissue inflammation by pro-resolving lipid mediators

  2024cites this paper
• Differential Modulation by Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) of Mesenteric Fat and Macrophages and T Cells in Adipose Tissue of Obese fa/fa Zucker Rats

  2024cites this paper
• Polymorphisms in Lymphotoxin-Alpha as the “Missing Link” in Prognosticating Favourable Response to Omega-3 Supplementation for Dry Eye Disease: A Narrative Review

  2023cites this paper
• Serum resolvin D1 potentially predicts neurofunctional recovery, the risk of recurrence and death in patients with acute ischemic stroke

  2023cites this paper
• Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid

  2023cites this paper
• Resolvin D1/N-formyl peptide receptor 2 ameliorates paclitaxel-induced neuropathic pain through the activation of IL-10/Nrf2/HO-1 pathway in mice

  2023cites this paper
• The therapeutic potential of resolvins in pulmonary diseases.

  2023cites this paper
• Resolvin D1 reprograms energy metabolism to promote microglia to phagocytize neutrophils after ischemic stroke.

  2023cites this paper
• The Effect of Very-Long-Chain n-3 Polyunsaturated Fatty Acids in the Central Nervous System and Their Potential Benefits for Treating Alcohol Use Disorder: Reviewing Pre-Clinical and Clinical Data

  2023cites this paper
• DHA Alleviated Hepatic and Adipose Inflammation with Increased Adipocyte Browning in High-Fat Diet-Induced Obese Mice.

  2023cites this paper
• The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation

  2023cites this paper
• Monocyte transcriptomic profile following EPA and DHA supplementation in men and women with low-grade chronic inflammation.

  2023cites this paper
• Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease

  2023cites this paper
• Oral ω-3 PUFA supplementation modulates inflammation in adipose tissue depots in morbidly obese women: A randomized trial.

  2023cites this paper
• The programming effect of plant-based DHA, along with equivalent ARA, on immune system and oral tolerance development in 6-week allergy prone BALB/c pups.

  2023cites this paper
• Dietary pyruvate targets cytosolic phospholipase A2 to mitigate inflammation and obesity in mice

  2023cites this paper
• Identification of omega-3 oxylipins in human milk-derived extracellular vesicles with pro-resolutive actions in gastrointestinal inflammation

  2023cites this paper
• Role of dysregulated macrophage subpopulation ratios and functional changes in the development of coronary atherosclerosis

  2023cites this paper
• RNA m6A modifications regulate crosstalk between tumor metabolism and immunity

  2023cites this paper
• From genes to systems: The role of food supplementation in the regulation of sepsis-induced inflammation.

  2023cites this paper
• Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases

  2023cites this paper
• The Roles of sPLA2s in Skin Homeostasis and Disease

  2023cites this paper
• Sex-Specific Differences in Resolution of Airway Inflammation in Fat-1 Transgenic Mice Following Repetitive Agricultural Dust Exposure

  2022cites this paper
• Bioactive lipids and metabolic syndrome—a symposium report

  2022cites this paper
• Resolvin D1 protects against sepsis-associated encephalopathy in mice by inhibiting neuro-inflammation induced by microglia.

  2022cites this paper
• Macrophages undergo a behavioural switch during wound healing in zebrafish.

  2022cites this paper
• Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn’s Disease

  2022cites this paper
• Resolvins lipid mediators: Potential therapeutic targets in Alzheimer and Parkinson disease.

  2022cites this paper
• The effect of resolvin D1 on bone regeneration in a rat calvarial defect model

  2022cites this paper
• Resolvin D1 attenuated liver injury caused by chronic ethanol and acute LPS challenge in mice

  2022cites this paper
• Topical Administration of a Marine Oil Rich in Pro-Resolving Lipid Mediators Accelerates Wound Healing in Diabetic db/db Mice through Angiogenesis and Macrophage Polarization

  2022influential citation
• Resolution of inflammation: Intervention strategies and future applications.

  2022cites this paper
• Chronic docosahexaenoic acid supplementation improves metabolic plasticity in subcutaneous adipose tissue of aged obese female mice.

  2022cites this paper
• The Gut Microbiota Metabolite Succinate Promotes Adipose Tissue Browning in Crohn’s Disease

  2022cites this paper
• Specialized pro-resolving mediators as modulators of immune responses.

  2022cites this paper
• New Insights Into the Interplay Among Autophagy, the NLRP3 Inflammasome and Inflammation in Adipose Tissue

  2022cites this paper
• Resolvins’ Obesity-Driven Deficiency: The Implications for Maternal–Fetal Health

  2022cites this paper
• Enhanced silver nanoparticle-induced pulmonary inflammation in a metabolic syndrome mouse model and resolvin D1 treatment

  2022cites this paper
• Intrinsic differences in rod and cone membrane composition: implications for cone degeneration

  2022cites this paper
• Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) for Immunomodulation in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)

  2022cites this paper
• An updated review of the effects of eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins on bone preservation.

  2022cites this paper
• The potential of marine resources for retinal diseases: a systematic review of the molecular mechanisms

  2021cites this paper
• Putting ATM to BED: How Adipose Tissue Macrophages Are Affected by Bariatric Surgery, Exercise, and Dietary Fatty Acids.

  2021cites this paper
• Docosahexaenoic acid lessens hepatic lipid accumulation and inflammation via the AMP-activated protein kinase and endoplasmic reticulum stress signaling pathways in grass carp (Ctenopharyngodon idella).

  2021cites this paper
• A unique adipocyte progenitor population promotes age-related adiposity

  2021cites this paper
• Macrophage Plasticity and Atherosclerosis Therapy

  2021cites this paper
• RvD1 accelerates the resolution of inflammation by promoting apoptosis of the recruited macrophages via the ALX/FasL-FasR/caspase-3 signaling pathway

  2021cites this paper
• Association between rs174537 FADS1 polymorphism and immune cell profiles in abdominal and femoral subcutaneous adipose tissue: an exploratory study in adults with obesity

  2021cites this paper
• Inositol hexaphosphate modulates the behavior of macrophages through alteration of gene expression involved in pathways of pro‐ and anti‐inflammatory responses, and resolution of inflammation pathways

  2021cites this paper
• 4-Acetylantroquinonol B ameliorates nonalcoholic steatohepatitis by suppression of ER stress and NLRP3 inflammasome activation.

  2021cites this paper
• Differential Tissue Metabolic Signatures in IgG4-Related Ophthalmic Disease and Orbital Mucosa-Associated Lymphoid Tissue Lymphoma

  2021cites this paper
• The Utilisation of Resolvins in Medicine and Tissue Engineering.

  2021cites this paper
• Dietary Docosahexaenoic Acid as a Potential Treatment for Semi-acute and Chronic Particle-Induced Pulmonary Inflammation in Balb/c Mice

  2021cites this paper
• Resolvin D1 reduces inflammation in co-cultures of primary human macrophages and adipocytes by triggering macrophages.

  2021cites this paper
• Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development

  2021cites this paper
• Macrophage origin, phenotypic diversity, and modulatory signaling pathways in the atherosclerotic plaque microenvironment

  2021cites this paper
• The effect of n- 3 polyunsaturated fatty acid supplementation on immune and reproductive parameters in dairy cows: a review

  2021cites this paper
• The effect of n- 3 polyunsaturated fatty acid supplementation on immune and reproductive parameters in dairy cows

  2021cites this paper
• Lipids as regulators of inflammation and tissue regeneration

  2021cites this paper
• Proresolving lipid mediators and liver disease.

  2021cites this paper
• Characterization of the liver proteome in dairy cows experiencing negative energy balance at early lactation.

  2021cites this paper
• Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders

  2021cites this paper
• Krill Oil Treatment Increases Distinct PUFAs and Oxylipins in Adipose Tissue and Liver and Attenuates Obesity-Associated Inflammation via Direct and Indirect Mechanisms

  2021cites this paper
• Spices, Condiments, Extra Virgin Olive Oil and Aromas as Not Only Flavorings, but Precious Allies for Our Wellbeing

  2021cites this paper
• Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders

  2021cites this paper
• A New Perspective on Cancer Therapy: Changing the Treaded Path?

  2021cites this paper
• The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury

  2020cites this paper
• Resolvin D1 Administration Is Beneficial in Trypanosoma cruzi Infection

  2020cites this paper
• Immunometabolism in type 2 diabetes mellitus: tissue-specific interactions

  2020cites this paper
• n-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging

  2020cites this paper
• Are marine n-3 fatty acids protective towards insulin resistance? From cell to human

  2020cites this paper
• A combination of LCPUFA ameliorates airway inflammation in asthmatic mice by promoting pro-resolving effects and reducing adverse effects of EPA

  2020cites this paper
• Practical Approaches in M2 Macrophage Biology: Analysis, Pharmacology, and Didactical Interpretation of M2 Macrophage Functions

  2020cites this paper